Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis

Arthritis Research & Therapy
Torsten Lowin, Rainer H Straub

Abstract

Chronic inflammation in rheumatoid arthritis (RA) is accompanied by activation of the sympathetic nervous system, which can support the immune system to perpetuate inflammation. Several animal models of arthritis already demonstrated a profound influence of adrenergic signaling on the course of RA. Peripheral norepinephrine release from sympathetic terminals is controlled by cannabinoid receptor type 1 (CB1), which is activated by two major endocannabinoids (ECs), arachidonylethanolamine (anandamide) and 2-arachidonylglycerol. These ECs also modulate function of transient receptor potential channels (TRPs) located on sensory nerve fibers, which are abundant in arthritic synovial tissue. TRPs not only induce the sensation of pain but also support inflammation via secretion of pro-inflammatory neuropeptides. In addition, many cell types in synovial tissue express CB1 and TRPs. In this review, we focus on CB1 and transient receptor potential vanilloid 1 (TRPV1)-mediated effects on RA since most anti-inflammatory mechanisms induced by cannabinoids are attributed to cannabinoid receptor type 2 (CB2) activation. We demonstrate how CB1 agonism or antagonism can modulate arthritic disease. The concept of functional antagonism with cont...Continue Reading

References

Nov 1, 1992·Annals of the Rheumatic Diseases·B L KiddD R Blake
Mar 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·M HerkenhamK C Rice
Jun 1, 1997·Annals of the Rheumatic Diseases·R D Situnayake, G Kitas
Jan 1, 1997·Pharmacology & Therapeutics·R G Pertwee
Apr 12, 2002·Current Pharmaceutical Design·Tiziana BisognoVincenzo Di Marzo
Oct 1, 2003·British Journal of Pharmacology·Ruth A Ross
Jul 22, 2004·Molecular Pharmacology·Kunlin JinDavid A Greenberg
Jan 22, 2005·Naunyn-Schmiedeberg's Archives of Pharmacology·Torsten PfitzerBela Szabo
Apr 16, 2005·The Journal of Pharmacology and Experimental Therapeutics·Arpád SzabóJános Szolcsányi
Apr 7, 2006·American Journal of Physiology. Cell Physiology·Mikhail Y KochukovKarin N Westlund
Jun 20, 2006·Experimental and Molecular Pathology·N J BartonI P Chessell
Jul 21, 2006·Annals of the New York Academy of Sciences·Peter Härle, Rainer H Straub
Sep 7, 2006·The Journal of Biological Chemistry·Nathaniel A JeskeKenneth M Hargreaves
Jul 21, 2007·British Journal of Pharmacology·J M McPartlandR G Pertwee
Aug 21, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Joseph TamItai Bab
Sep 19, 2007·British Journal of Pharmacology·E RybergP J Greasley
Dec 14, 2007·Physiology & Behavior·Jack BergmanAlex Makriyannis
Jan 1, 2008·Arthritis and Rheumatism·Charles G HelmickUNKNOWN National Arthritis Data Workgroup
Feb 1, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Armen N AkopianKenneth M Hargreaves
Feb 1, 2008·Molecular Medicine·Herbert Tilg, Alexander R Moschen
Sep 30, 2008·Arthritis and Rheumatism·Adriana del ReyRainer H Straub
Nov 11, 2008·Recent Patents on Cardiovascular Drug Discovery·Ashish SamatG Neil Thomas

❮ Previous
Next ❯

Citations

Jan 27, 2016·Autoimmunity Reviews·Yaxiong DengYehuda Shoenfeld
Mar 29, 2019·Current Opinion in Rheumatology·Torsten LowinGeorg Pongratz
Aug 25, 2019·Der Schmerz·Christoph Wendelmuth, Knud Gastmeier
Nov 11, 2016·Current Rheumatology Reports·Mary-Ann Fitzcharles, Winfried Häuser
Jun 10, 2018·Nature Reviews. Rheumatology·Daphna Katz-TalmorYehuda Shoenfeld
Nov 30, 2018·Drugs & Aging·Amir MinerbiMary-Ann Fitzcharles
Jan 31, 2019·Frontiers in Molecular Neuroscience·Chanté MullerPatricia H Reggio
Sep 10, 2020·ImmunoTargets and Therapy·Nadia PeyravianJoaquin J Jimenez
Jun 9, 2020·Current Pain and Headache Reports·John WolfOmar Viswanath
Jun 15, 2017·Frontiers in Molecular Neuroscience·Eric Murillo-RodríguezGloria Arankowsky-Sandoval
Dec 14, 2018·Frontiers in Pharmacology·Sonja VučkovićMilica Prostran
Dec 13, 2018·Frontiers in Pharmacology·Li WuWei Wei
Jun 9, 2020·British Journal of Pharmacology·Belén PalomaresEduardo Muñoz
Nov 8, 2020·Joint, Bone, Spine : Revue Du Rhumatisme·Bo XieXiuzu Song
Jan 28, 2021·International Journal of Molecular Sciences·Ana Lago-FernandezPaula Morales
Feb 17, 2021·Critical Reviews in Food Science and Nutrition·Fengzhang WangXiaojun Liao
Mar 6, 2021·Journal of Animal Science and Biotechnology·Madison N MyersG Andres Contreras
Apr 5, 2021·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Ismini KyriakouElena Polycarpou
Apr 24, 2021·Neuroscience Letters·Fatma Nihan CankaraCaner Günaydın
Jun 4, 2021·Frontiers in Molecular Neuroscience·Sumana GhoshBradley J Walters
Aug 28, 2021·International Journal of Molecular Sciences·Annia A Martínez-PeñaSandeep Raha

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here